C10orf67 Inhibitors
The functional activity of C10orf67 can be inhibited through various chemical compounds that interact with specific pathways or cellular processes. Inhibitors that modulate epigenetic markers play a significant role in this context; for example, compounds that inhibit histone deacetylases can lead to changes in chromatin structure, resulting in a reduced expression of C10orf67. Similarly, compounds that target DNA methylation processes can alter gene expression profiles, potentially diminishing the transcriptional activity of the C10orf67 gene. These epigenetic modulators exert a profound impact on gene expression regulation, which in turn can influence the levels and function of C10orf67 in the cell.
Furthermore, small molecules that target key signaling pathways also serve as effective inhibitors of C10orf67. For instance, compounds that inhibit the mTOR pathway can impede the translation of certain mRNA populations, which would include C10orf67 if it falls under mTOR's regulatory umbrella. Inhibition of the PI3K/Akt pathway, a critical signaling cascade involved in cell survival and proliferation, could also lead to decreased stability or translation of C10orf67. Additionally, inhibitors of the MAPK/ERK and p38 MAPK pathways can suppress the expression of C10orf67 given its regulation is connected to these pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This hydroxamic acid functions as a histone deacetylase inhibitor. By altering chromatin structure, it can decrease C10orf67 expression as genes tightly wrapped around histones are less transcriptionally active. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog that incorporates into DNA and RNA. It inhibits DNA methyltransferases, leading to reduced methylation of the C10orf67 gene promoter, which may result in decreased expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect the translation of a subset of mRNA by inhibiting the mTOR pathway, reducing the synthesis of C10orf67 given it is under mTOR control. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinases (PI3K) inhibitor, which can downregulate the PI3K/Akt pathway, decreasing the stability or translation of C10orf67 given it is PI3K/Akt-dependent. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor that by blocking the MAPK/ERK pathway may downregulate C10orf67 given its expression is dependent on this signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that may decrease the expression or activity of C10orf67 given it is regulated by stress-activated protein kinase pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent PI3K inhibitor that could decrease C10orf67 activity by inhibiting the PI3K/Akt pathway given it is upstream of C10orf67. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK). Given the activity of C10orf67 is JNK-dependent, inhibiting JNK could reduce its activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that could decrease the protein levels of C10orf67 by preventing the degradation of regulatory proteins that stabilize C10orf67 mRNA or protein. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
An inhibitor of eukaryotic protein synthesis that can nonspecifically reduce the levels of C10orf67 by blocking translation. | ||||||